A new butenolide, aspernolide D (1), and furandione, asperterone (2), together with four known butenolides, butyrolactones I-IV and aspernolide B, were obtained from cultures of the endophytic fungus Aspergillus terreus, isolated from the flowering plant Mammea siamensis. The structures of these compounds were elucidated by analysis of NMR spectroscopic and mass spectrometric data.
Note
Endophytic fungi have proved to be a rich source of bioactive secondary metabolites, 1, 2) and recently several novel bioactive substances have been isolated from these microorganisms. [3] [4] [5] Aspergillus terreus has been isolated from both marine and terrestrial sources and is well known for the production of butenolides. In the course of our search for biologically active metabolites from endophytic fungi from Thai medicinal plants, a subculture of an isolate of A. terreus, obtained from the leaves of Mammea siamensis, was cultivated in medium containing corn steep liquor. We report here the isolation and structural elucidation of a new butenolide, aspernolide D (1), and furandione, asperterone (2) , together with four known butenolides, butyrolactones I-IV 6, 7) and aspernolide B, 8) and the evaluation of compounds 1 and 2 for their antibacterial activity against both Gram-positive and Gram-negative bacteria. To the best of our knowledge, this is the first report of butyrolactone III from a natural source.
Results and Discussion
The EtOAc crude extract of the culture broth of A. terreus RCBC 1002 was successively subjected to Sephadex LH20 and silica gel column chromatography to afford butyrolactones I and II as major constituents. Compounds 1 and 2 ( Fig. 1) , as well as butyrolactones III, IV, and aspernolide B, were isolated as minor metabolites according to TLC analyses.
Aspernolide D (1) was isolated as a light yellow gum and its molecular formula was assigned to be C 24 H-and 13 C-NMR data of 1 were closely related to those of butyrolactone I, but with differences evident in the region of side chain unit (C-7Љ to C-11Љ). Observed HMBC correlations from Me-10Љ to C-8Љ and C-9Љ, from Me-11Љ to C-8Љ and C-9Љ, and from H 2 -7Љ to C-8Љ were indicative of the presence of a dihydroxyl group at C-8Љ and C-9Љ in 1 instead of the D 8Љ,9Љ double bond for butyrolactone I. The absolute stereochemistry at C-8Љ of 1 was assigned by application of the modified Mosher's method. 9, 10) The difference in chemical shift values (Ddϭd S Ϫd R ) for its a-methoxy-a-(trifluoromethyl)phenylacetic acid (MTPA) esters, 1a and 1b, indicated the S-configuration at C-8Љ (Fig. 2) .
As the co-metabolite, butyrolactone I was determined to have the 4R-confiugration by comparison of specific rotation data, [a] D ϩ84.32, with the previously reported result. 6) Therefore the stereochemistry at C-4 of 1 could also be deduced to be 4R based on biosynthetic grounds and similarity of the specific rotation, [a] D ϩ40. In addition, compound 1 was treated with NaIO 4 to yield the corresponding aldehyde to remove another chiral center at C-8Љ, but one of the products obtained was butyrolactone IV, 7) not the desired aldehyde. However, this helped to confirm the 4R-configuration at C-4 of 1. The most plausible biosynthetic pathway for the formation of compound 1 from butyrolactone I is the epoxidation of the D 7Љ,8Љ double bond to give another co-metabolite, butyrolactone III, followed by ring-opening with water, as shown in Chart 1.
Butenolide and Furandione from an Endophytic Aspergillus terreus
Asperterone (2) was isolated as a yellow gum. The molecular formula C 22 H 20 O 5 was established on the basis of the [MϩNa] ϩ peak at m/z 387.1210 (Calcd 387.1208) in the HR-ESI-MS, implying 13 degrees of unsaturation. The NMR spectrum of 2 (Table 1 ) displayed a similar signal pattern to those of butyrolactone I for a para-disubstituted benzene ring, a trisubstituted benzene ring with an isopentenyl unit at C-3Љ, except for the absence of the carbomethoxy moiety and the presence of an additional ester carbonyl group. The existence of the furan-3-en-2,5-dione at the central core was corroborated by HMBC correlations from H-2Ј to C-3, from H 2 -6 to both ester carbonyl carbons (C-2, C-5) at d C 165.1 and 166.1, and from H 2 -6 to D 3,4 olefinic carbons, which were considerably deshielded to resonate at d C 139.7 and 137.6, respectively. This suggests that each of these olefinic carbons should be connected to the ester carbonyls. In addition, two aromatic rings, an isopentenyl group, two carbonyls, and a double bond account for a total of 12 unsaturation units, and thus the two ester groups must be connected through an oxygen atom to form a furandione ring, consistent with another unsaturation remaining. Therefore the structure of 2 was established as shown. This compound gradually decomposed in CDCl 3 .
Compounds 1 and 2 were tested for their antibacterial activity against five Gram-positive bacteria (Bacillus subtilis, Staphylococcus aureus, Staphylococcus hominis, Staphylococcus epidermidis, and Enterococcus faecalis), and four Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris, and Salmonella typhimurium). Unfortunately, both compounds were inactive against all bacterial strains tested (minimum inhibitory concentration (MIC) Ͼ256 mg/ml).
Experimental
General Experimental Procedures Optical rotations were measured on a Perkin-Elmer 341 polarimeter using a sodium lamp at wavelength of 589 nm, and UV data were recorded on a Shimadzu UV-160 spectrophotometer. IR spectra were recorded on a Bruker vector22 Fourier-transform infrared spectrophotometer. The NMR spectra were recorded on a Varian YH400 spectrometer at 400 MHz for 1 H-NMR and at 100 MHz for 13 C-NMR using tetramethylsilane as the internal standard. HR-ESI-MS were obtained using a Bruker micrOTOF mass spectrometer. Vol. 58, No. 9 Chart 1. Proposed Biosynthetic Pathway of 1 The isolate was subcultured on potato dextrose agar plates at 25°C for 7 d. Agar plugs were used to inoculate 1000-ml Erlenmeyer flasks, each containing 200 ml of medium (corn steep liquor 1 g, mannitol 10 g, maltose 10 g, glucose 5 g, monosodium glutamate 10 g, KH 2 PO 4 0.5 g, MgSO 4 · 7H 2 
Extraction and Isolation Ten-liter cultures were filtered, and the culture broth was extracted with EtOAc (ϫ3). The combined organic layer was concentrated to afford the crude extract (12.60 g). The extract was fractionated by Sephadex LH20 column chromatography eluted with MeOH to yield six fractions (I-VI). Fraction III was chromatographed on a silica gel column eluted with acetone-benzene (1 : 3) to give butyrolactone I (2.76 g), butyrolactone II (1.64 g), aspernolide B (346.0 mg), and 10 subfractions (III-1 to III-10). Subfraction III-1 was subjected to flash silica gel column chromatography (acetone-benzene, 1 : 9) and further purified on a silica gel column (hexane-acetone, 3 : 1) to afford 2 (8.2 mg), whereas purification of subfraction III-7 by flash column chromatography eluted with MeOHCHCl 3 (1 : 30) gave 1 (16.2 mg) and butyrolactone III (45.5 mg). Fraction III-8 was rechromatographed on a silica gel column (acetone-benzene, 1 : 2) followed by preparative TLC (MeOH-CH 2 Cl 2 , 5 : 95) to yield butyrolactone IV (9.2 mg).
Aspernolide D (1) Preparation of MTPA Ester Derivatives of 1 To a solution of 1 (3.0 mg) in pyridine (0.3 ml) was added (R)-MTPA Cl (20 ml).
9,10) The reaction mixture was stirred at room temperature overnight. The mixture was diluted with EtOAc and washed with H 2 O and 1 M NaHCO 3 , and the organic layer was concentrated under reduced pressure. The residue was purified on a short silica gel column (MeOH-CH 2 Cl 2 ) to obtain the (S)-MTPA ester 1a (1. Similarly, the reaction mixture of 1 (3.0 mg), (S)-MTPA Cl (20 ml) and pyridine (0.3 ml) was processed as described above for 1a to afford 1b (1.5 , H-6b), 3.00 (2H, m, H 2 -7Љ), 1.22 (3H, s, Me-10Љ), 1.19 (3H, s, 
Me-11Љ).
Biological Assays A broth microdilution method was used to determine the MIC according to the NCCLS protocol. 11, 12) Five reference Gram-positive bacteria, B. subtilis ATCC 6633, S. aureus ATCC 25923, S. hominis ATCC 27844, S. epidermidis ATCC 12228 and E. faecalis ATCC 29212; and four Gram-negative bacteria, E. coli ATCC 35218, P. aeruginosa ATCC 27853, P. vulgaris ATCC 13315 and S. typhimurium ATCC 13311 were used. All tests were performed in Mueller-Hinton broth. Serial doubling dilutions of the compound, prepared in a 96-well microtiter plate, ranged from 0.5 to 256 mg/ml. The final concentration of each strain was adjusted to 5ϫ10 5 colony forming unit (CFU)/ml. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of the compound at which the microorganism did not demonstrate visible growth as determined by turbidity.
